fatigue; chest pain; dyspnoea; drug ineffective; sars-cov-2 infection; myopericarditis; this is a spontaneous report received from a contactable reporter(s) (physician) from the regulatory authority and product quality group. regulatory number: gb-mhra-webcovid-202202231930556860-ayqm4. other case identifier(s): gb-mhra-adr 26642983. a 37 year-old female patient (not pregnant) received bnt162b2 (bnt162b2), administration date 22may2021 (lot number: et8885) as dose 1, single for covid-19 immunisation; colchicine (colchicine) (batch/lot number: unknown); losartan potassium (losartan potassium) (batch/lot number: unknown). relevant medical history included: "suspected covid-19" (unspecified if ongoing), notes: unsure when symptoms started, unsure when symptoms stopped. patient was not enrolled in clinical trial, not had a covid-19 test, was not pregnant, was not currently breastfeeding and was fit and well previously. the patient's concomitant medications were not reported. the following information was reported: drug ineffective (disability, medically significant) with onset 26sep2021, outcome "recovered with sequelae", described as "drug ineffective"; covid-19 (disability, medically significant) with onset 26sep2021, outcome "recovered with sequelae", described as "sars-cov-2 infection"; myocarditis (disability) with onset 13jun2021, outcome "recovering", described as "myopericarditis"; fatigue (disability), outcome "unknown", described as "fatigue"; chest pain (disability), outcome "unknown", described as "chest pain"; dyspnoea (disability), outcome "unknown", described as "dyspnoea". the events "sars-cov-2 infection", "myopericarditis", "fatigue", "chest pain" and "dyspnoea" were evaluated at the physician office visit. the patient underwent the following laboratory tests and procedures: blood test: (unspecified date) small troponin rise, notes: small troponin rise; chest x-ray: (13jun2021) r basal consolidation; computerised tomogram: (unspecified date) unobstructed coronary arteries; computerised tomogram thorax: (unspecified date) normal, notes: normal; electrocardiogram: (13jun2021) no mention that it was abnormal; (17jun2021) normal apart from mild global early repolarisation; magnetic resonance imaging heart: (unspecified date) pericardial effusion lvef 68% no inflammation; (unspecified date) still pericardial effusion but improved; troponin: (13jun2021) 28, notes: 28. the action taken for colchicine and losartan potassium was unknown. therapeutic measures were taken as a result of covid-19, myocarditis, fatigue, chest pain, dyspnoea. treatment given nsaids, steroids or other anti inflammatory agents: "colchicine, losartan". clinical course: had first covid vaccine and did a triathlon a few days later, developed chest pain and was diagnosed subsequently with myopericarditis no follow-up attempts are needed. no further information is expected

test name: blood tests; result unstructured data: test result:small troponin rise; comments: small troponin rise; test date: 20210613; test name: chest x-ray; result unstructured data: test result:r basal consolidation; test name: cardiac ct; result unstructured data: test result:unobstructed coronary arteries; test name: chest ct; result unstructured data: test result:normal; comments: normal; test date: 20210613; test name: ecg; result unstructured data: test result:no mention that it was abnormal; test date: 20210617; test name: ecg; result unstructured data: test result:normal apart from mild global early repolarisation; test name: cardiac mri; result unstructured data: test result:pericardial effusion lvef 68% no inflammation; test name: cardiac mri; result unstructured data: test result:still pericardial effusion but improved; test date: 20210613; test name: cardiac troponin; result unstructured data: test result:28; comments: 28

na

na